COVID+RESPI

Respiratory Pathogen

PCR BASED TESTING

Acute respiratory infection remains the leading cause of death amongst geriatric and immuno-compromised patients. For infectious diseases that interfere with normal breathing, it is essential to detect multiple pathogens simultaneously.

Genetic identification of respiratory infections with an unequalled accuracy rate of 99.8%.

Our PCR based RESPI test is 3-5x more sensitive than conventional culture techniques and allows MHS Labs to report results for both infection identification and antibiotic resistance within 12-24 hours of lab arrival.

make clinical decisions on a wide array of infections
reduce the time to treatment
target and personalize therapy

For partnering facilities, the RESPI program includes antibiotic stewardship to reduce risk, adverse events and readmissions.

Respiratory Pathogens

Viruses
Adenovirus
Coronavirus 229E
Coronavirus HKU1
Coronavirus NL63
Coronavirus OC43
Enterovirus
Human Bocavirus
Human Metapneumovirus
Human Rhinovirus
Inﬂuenza A, AH1 & A H3
Inﬂuenza B
Parainﬂuenza 1, 2, 3 & 4
Respiratory Syncytial Virus A & B

Fungi
Asperigillus niger
Asperigillus fumigatus
Asperigillus ﬂavus
Asperigillus clavatus
Cryptococcus neoformans
Cladosporium herbarum
Penicillium chrysogenum

Bacteria
Acinetobacter baumannii
Bartonella henselae
Bordetella pertussis
Chlamydia pneumoniae
Gordonia bronchialis
Haemophilus inﬂuenzae
Klebsiella pneumoniae
Legionella pneumoniae
Moraxella catarrhalis
Mycobacterium avium
Mycobacterium kansakii
Mycobacterium tuberculosis
Mycoplasma pneumoniae
Neisseria meningitides
Staphylococcus aureus
Streptococcus pneumoniae
Streptococcus pryogens

Antibiotic resistance genes
mecA, mecC, blaSHV-5, mcr-1,
VanA, VanB, grlA,
1546 Transposon, Cfr23S,
ampC, ermB, tetM, tetS